MPO and alkaline phosphatase measurement: In addition, galunisertib treatment significantly alleviated edema, hemorrhage, necrosis, and inflammatory responses of TAC-induced experimental AP in rats, and decreased AP markers, AMY, LIP, and MPO activity.